![Documents Document Submission](/images/default-source/default-album/document-review/documents.jpg?sfvrsn=d9b80dc1_1)
Rate This Document
Application of Phase-Appropriate CGMP and Quality Systems to the Development of Protein Bulk Drug Substance or API
- Description: Application of Phase-Appropriate CGMP and Quality Systems to the Development of Protein Bulk Drug Substance (or API)
- Published on: Nov 16, 2023
- Rating Period:
Your rating for this document has already been submitted